Welcome to the 3D Bioprinting Core Facility
3D Bioprinting Core Facility (3D-BCF)
The primary objective of the 3D Bioprinting Core Facility is to utilize advanced 3D bioprinting and nanoprinting to reproduce the 3D architecture of biological tissue and tumor tissue.
This approach will enable the production of tissue-surrogates for screening of therapeutics and potentially toxic substances, thus reducing the reliance on animal testing.
In the medium term, the generation of patient-specific tissue will facilitate the screening of drugs tailored to the genetic characteristics of an individual patient (personalized medicine, e.g. in the context of cancer treatment) and the generation of tissue substitutes for tissue regeneration and replacement.
Highlights
- Little talks Podcast – #241 with Judith Hagenbuchner
In the podcast interview, Judith Hagenbuchner talks to podcast host Robert Pacher about the 3D bioprinting lab, developments, longevity and much more. - Wissen leben Podcast, Episode 4: A tumor grows in gelatineMolecular biologist Judith Hagenbuchner in conversation with Laurin Mauracher – How can we test 120 potential active substances quickly and realistically if we don’t want to carry out animal experiments?
- Film report on Puls24 – Medicine: A future without animal testing?3D bioprinting brings new hope. to the video on Puls24
- Tuba Prize 2021: Artificial skin from the 3D bioprinterThe aging of the skin is the focus of the Tuba research grant-funded project by Michael Außerlechner, who conducts research at the University Department of Pediatrics and, together with his colleague Judith Hagenbuchner, heads the 3D bioprinting laboratory – the first of its kind in Austria.
- Online article medsolut.com: The human being from the 3D printer? News about the science and art of bioprinting
online article on medsolut.com
